Literature DB >> 3326028

Ribonucleotide reductase inhibitors as anticancer and antiviral agents.

E J Lien.   

Abstract

Mesh：

Substances：

Year:  1987        PMID： 3326028     DOI： 10.1007/978-3-0348-9289-6_2

Source DB:  PubMed          Journal:  Prog Drug Res        ISSN： 0071-786X


× No keyword cloud information.
  7 in total

1.  Implications and problems in analysing cytotoxic activity of hydroxyurea in combination with a potential inhibitor of ribonucleotide reductase.

Authors:  G Nocentini; A Barzi; P Franchetti
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Cellular delivery of nucleoside diphosphates: a prodrug approach.

Authors:  S H Kang; A K Sinhababu; J G Cory; B S Mitchell; D R Thakker; M J Cho
Journal:  Pharm Res       Date:  1997-06       Impact factor: 4.200

3.  A phase I pharmacodynamic study of GTI-2040, an antisense oligonucleotide against ribonuclotide reductase, in acute leukemias: a California Cancer Consortium study.

Authors:  Mark H Kirschbaum; Paul Frankel; Timothy W Synold; Zhiliang Xie; Yun Yen; Leslie Popplewell; Robert Chen; Omar Aljitawi; Joseph M Tuscano; Kenneth K Chan; Edward M Newman
Journal:  Leuk Lymphoma       Date:  2016-02-19

4.  Synthesis and testing of new antileukemic Schiff bases of N-hydroxy-N'-aminoguanidine against CCRF-CEM/0 human leukemia cells in vitro and synergism studies with cytarabine (Ara-C).

Authors:  P B Koneru; E J Lien; V I Avramis
Journal:  Pharm Res       Date:  1993-04       Impact factor: 4.200

5.  The expression of ribonucleotide reductase M2 in the carcinogenesis of uterine cervix and its relationship with clinicopathological characteristics and prognosis of cancer patients.

Authors:  Ying-Fang Su; Tzu-Fan Wu; Jiunn-Liang Ko; Hsiu-Ting Tsai; Yi-Torng Tee; Ming-Hsien Chien; Chi-Hung Chou; Wea-Lung Lin; Hui-Ying Low; Ming-Yung Chou; Shun-Fa Yang; Po-Hui Wang
Journal:  PLoS One       Date:  2014-03-17       Impact factor: 3.240

6.  A functional approach reveals a genetic and physical interaction between ribonucleotide reductase and CHK1 in mammalian cells.

Authors:  Lorena Taricani; Frances Shanahan; Maria-Christina Malinao; Maribel Beaumont; David Parry
Journal:  PLoS One       Date:  2014-11-06       Impact factor: 3.240

7.  Inhibition of human adenoviruses by 1-(2'-hydroxy-5'-methoxybenzylidene)amino-3-hydroxyguanidine tosylate.

Authors:  M B Hui; E J Lien; M D Trousdale
Journal:  Antiviral Res       Date:  1994-08       Impact factor: 5.970
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.